Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
Condition: Pediatric Gastroesophageal Reflux DiseaseIntervention: Drug: DexlansoprazoleSponsor: TakedaNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2015 Category: Research Source Type: clinical trials
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease
Condition: Gastroesophageal Reflux DiseaseInterventions: Drug: Dexlansoprazole 30 mg; Drug: Dexlansoprazole 60 mgSponsor: TakedaRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2015 Category: Research Source Type: clinical trials